Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients

Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients

Abstract Background Portal vein thrombosis (PVT) is a common complication of cirrhosis. However, in patients with PVT and cirrhosis, there is no clear evidence supporting effective treatment modalities. In this study, we examined the effectiveness and safety of anticoagulation therapy using danaparo...

Full description

Bibliographic Details
Main Authors: Takehiro Hayashi, Hajime Takatori, Rika Horii, Kouki Nio, Takeshi Terashima, Noriho Iida, Masaaki Kitahara, Tetsuro Shimakami, Kuniaki Arai, Kazuya Kitamura, Kazunori Kawaguchi, Taro Yamashita, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Tadashi Toyama, Kenichiro Okumura, Kazuto Kozaka, Shuichi Kaneko
Format: Article
Language:English
Published: BMC 2019-12-01
Series:BMC Gastroenterology
Subjects:
Portal vein thrombosis
Liver cirrhosis
Danaparoid sodium
Antithrombin III
Online Access:https://doi.org/10.1186/s12876-019-1140-8

Internet

https://doi.org/10.1186/s12876-019-1140-8

Similar Items